Recently, GLP-1 receptor agonists have received level of popularity for their performance in weight-loss/administration and appetite suppression. Considered one of the newest additions to this class of peptide drugs is known as Retatrutide, a medication that has demonstrated promising ends in clinical trials.Nonetheless, current analysis suggests t